CRMD Competitors & Alternatives
Compare CorMedix Inc with similar stocks in the same industry
Biotechnology
CRMD
Main Stock$4.70
-2.59%
Tradestie Score
56
Market Cap
$862.55M
P/E Ratio
2.4
Revenue Growth
-47.7%
Analyst Upside
+201.7%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALMS
Alumis Inc. Common Stock
|
$4.73
-8.07%
|
$422.50M | - | 45 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.74
-4.87%
|
$407.71M | - | 51 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$9.83
-0.96%
|
$386.68M | - | 47 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.15
-0.97%
|
$382.04M | - | 35 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.03
+0.50%
|
$371.64M | - | 44 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$8.62
+3.86%
|
$357.51M | - | 38 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$9.03
-4.95%
|
$354.45M | - | 41 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$39.15
-8.93%
|
$353.70M | - | 43 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.49
-2.38%
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$19.74
-7.80%
|
$328.62M | - | 32 | Compare |
More CRMD Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry